1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Adjuvant Therapy: new trials by email Literature Review of Adjuvant Therapy trials Research Report on Adjuvant Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery SOX, XELOX, PD-1 antibody - MSI-H, PD-1 Immunotherapy | Phase 2 | Active not recruiting | Fudan University | 94 | 2022-08-01 | 2026-08-11 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Stomach Diseases (1)
XELOX (1) · spartalizumab (1)
Fudan University (1)
China (1)
PMID 26028255, PMID 28241187, PMID 29727332, PMID 31513484, PMID 32251400